
CHOSA Oncology AB
CHOSA | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0007784319
- LEI:
- 5493002SFL9YXB0A0027
- Country:
- Sweden
- Address:
- C/O Medicon Village, C/O Medicon Village, Scheeletorget 1, 223 81 Lund
- Website:
- https://www.chosaoncology.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
CHOSA Oncology AB is a clinical-stage biotechnology company focused on developing solutions for precision oncology. The company's main assets are Platin-DRP™ and LiPlaCis®. Platin-DRP™ is a patented diagnostic tool that analyzes a 205-gene signature in a patient's tumor to predict their response to platinum-based chemotherapies, such as cisplatin and carboplatin. This enables personalized treatment plans, aiming to improve survival rates and avoid overtreatment. LiPlaCis® is a novel drug formulation that delivers cisplatin within a specialized liposome, designed to target tumors directly and reduce harmful side effects. CHOSA's business strategy includes forming partnerships and sublicensing agreements to advance the clinical development and commercialization of its products for cancer patients worldwide.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for CHOSA Oncology AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
No filings match the current criteria. |
Automate Your Workflow. Get a real-time feed of all CHOSA Oncology AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CHOSA Oncology AB via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |